TCL Archive NCI, FDA, Correlogic To Begin Large Trial Of Protein Pattern Diagnostic System for Ovarian Cancer June 28, 2002
TCL Archive Adverse data from cancer prevention trial makes Merck withdraw Vioxx from market. Researchers discuss implications for other cancer prevention trials. October 15, 2004
TCL Archive In Brief: Hopkins Gets $10 Million for Directorships, to Dedicate New Clinical Cancer Building October 22, 1999
